Nosenzo John
- SEC CIK
- 0001835973
No open-market purchases or sales filed in the past year.
Current role at each company
- TELA TELA Bio, Inc.Directoras of Jun 2, 2023
- BVS Bioventus Inc.Fmr. Chief Commercial Officeras of Apr 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nosenzo John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BVS Bioventus Inc.
Fmr. Chief Commercial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2023 (view filing) | Apr 1-Oct 3, 2022 | 385 daysLate | Nosenzo JohnFmr. Chief Commercial Officer | SSaleClass A Common Stock | −142 | $8.81 | −$1.25K | −0.2%87.1K after | 3 lots10b5-1 |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Nosenzo JohnChief Commercial Officer | SSaleClass A Common Stock | −66.0K | $11.12 | −$733.5K | −44.0%83.9K after | |
| Feb 15, 2022 (view filing) | Feb 14 | 1 day | Nosenzo JohnChief Commercial Officer | SSaleClass A Common Stock | −534 | $11.99 | −$6.40K | −1.2%43.4K after |